Azacitidine Shows Promise in Treating VEXAS Syndrome

Azacitidine shows promising effectiveness and favorable glucocorticoid-sparing effects in patients with genetically confirmed VEXAS syndrome.
Medscape Medical News

source https://www.medscape.com/viewarticle/azacitidine-shows-promise-treating-vexas-syndrome-2025a1000gbx?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension